HER2-Positive Breast Cancer: What Surgeons Need To Know
Join our expert faculty in a Live Virtual Symposium as they discuss therapeutic approaches for patients with HER2-positive early breast cancer.
The latest evidence and rationale for neoadjuvant and adjuvant treatment strategies will be discussed, as well as optimal application in routine practice.
What do surgeons need to know? Please come with your most pressing questions.
This program is developed in Partnership with Medscape Education Global.
To register Click Here
Tibor Kovacs, PhD, FRCS, FEBS, Med. Habil.
Honorary Senior Lecturer
King's College London
Guy's Hospital Breast Unit, London
Chief of Surgical Oncology and
Breast Surgery Jiahui Health, Shanghai
Christian Jackisch, MD, PhD
Department of Obstetrics and Gynecology and Breast Cancer Center
Sana Klinikum Offenbach
Michael Knauer, MD, PhD, FEBS
Head of Breast Surgery
Breast Cancer Eastern Switzerland
St Gallen, Switzerland
PROGRAM Friday, 16 October 2020